NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
Jimmy J. Caudell,Maura L. Gillison,Ellie Maghami,Sharon A. Spencer,David G. Pfister,Douglas Adkins,Andrew C. Birkeland,David M. Brizel,Paul M. Busse,Anthony J. Cmelak,A. Dimitrios Colevas,David W. Eisele,Thomas J. Galloway,Jessica L. Geiger,Robert I. Haddad,Wesley L. Hicks,Ying J. Hitchcock,Antonio Jimeno,Debra S. Leizman,Loren K. Mell,Bharat B. Mittal,Harlan A. Pinto,James W. Rocco,Cristina Rodríguez,Panayiotis Savvides,David L. Schwartz,Jatin P. Shah,David J. Sher,Maie A. St. John,Randal S. Weber,Gregory S. Weinstein,Frank Worden,J. Yang Bruce,Sue S. Yom,Weining Zhen,Jennifer L. Burns,Susan Darlow +36 more
431
TL;DR: The NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.
read more
Abstract: The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma
Xin Liu,Hui Shen,Lu Zhang,Wen-hui Huang,Shui Xing Zhang,Bin Zhang +5 more
TL;DR: Immunotherapy, particularly ICIs and adoptive cell therapy, shows promise in treating recurrent or metastatic nasopharyngeal carcinoma, but further research is needed to enhance efficacy through combination therapies and biomarker-based scoring systems to identify suitable candidates.
4
Avasopasem for the treatment of radiotherapy-induced severe oral mucositis
TL;DR: Avasopasem manganese is a selective superoxide dismutase mimetic being developed by Galera Therapeutics, which recently submitted a New Drug Application (NDA) to the FDA for a severe oral mucositis (OM) indication as discussed by the authors .
4
A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The "ALARM" study.
Sofia Agelaki,Ioannis Boukovinas,Ilias Athanasiadis,Georgios Trimis,Ioannis Dimitriadis,Lazaros Poughias,Edith Morais,Ugne Sabale,Goran Benčina,Charalampos Athanasopoulos +9 more
TL;DR: Over the last decade, at least one quarter of LA/RM HNC and half of OPC cases studied in IS and NIS were HPV+.
4
Image-Guided Intraoperative Assessment of Surgical Margins in Oral Cavity Squamous Cell Cancer: A Diagnostic Test Accuracy Review
Luca Disconzi,Elena Casiraghi,Guido Costa,Armando De Virgilio,Andrea Esposito,Fabio Ferreli,Antonio Lo Casto,Silvia Marra,Luca Malvezzi,Giuseppe Mercante,Giuseppe Spriano,Guido Torzilli,Marco Francone,Luca Balzarini,Caterina Giannitto +14 more
TL;DR: The diagnostic test accuracy (DTA) review as discussed by the authors investigated the accuracy of intraoperative imaging in the assessment of oral cavity squamous cell cancer (OCSCC) margins, and concluded that IoUS showed comparable accuracy to that of ex vivo MRI for the diagnosis of close and involved surgical margins.
Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy
Wenhui Huang,Kun Wang,Wei-Yuan Huang,Zicong He,Jingming Zhang,Bin Zhang,Zhiyuan Xiong,Kelly M. Gillen,Wenzhe Li,Feng Chen,Xing Yang,Shui Xing Zhang,Jie Tian +12 more
TL;DR: Coupled with CAIX-800, US-guided sPA imaging could not only detect subcapsular deposits of metastatic cancer cells 2 weeks earlier than conventional techniques, but also successfully track pathological ENE.
3
References
•Book
AJCC Cancer Staging Manual
Mahul B. Amin,Stephen B. Edge,Frederick L. Greene,David R. Byrd,Robert K. Brookland,Mary Kay Washington,Jeffrey E. Gershenwald,Carolyn C. Compton,Kenneth R. Hess,Daniel C. Sullivan,J. Milburn Jessup,James D. Brierley,Lauri E. Gaspar,Richard L. Schilsky,Charles M. Balch,David P. Winchester,Elliot A. Asare,Martin Madera,Donna M. Gress,Laura R. Meyer +19 more
- 17 Sep 2013
TL;DR: Purposes and Principles of Cancer Staging and End-Results Reporting are explained.
20.9K
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang,Jonathan Harris,Richard H. Wheeler,Randal S. Weber,David I. Rosenthal,Phuc Felix Nguyen-Tân,William H. Westra,Christine H. Chung,Richard C.K. Jordan,Charles Lu,Harold Kim,Rita Axelrod,C Craig Silverman,Kevin P. Redmond,Maura L. Gillison +14 more
TL;DR: Tumor HPV status is a strong and independent prognostic factor for survival among patients with oropharyngeal cancer and the risk of death significantly increased with each additional pack-year of tobacco smoking.
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Anil K. Chaturvedi,Eric A. Engels,Ruth M. Pfeiffer,Brenda Y. Hernandez,Weihong Xiao,Esther Kim,Bo Jiang,Marc T. Goodman,Maria Sibug-Saber,Wendy Cozen,Lihua Liu,Charles F. Lynch,Nicolas Wentzensen,Richard C.K. Jordan,Sean F. Altekruse,William F. Anderson,Philip S. Rosenberg,Maura L. Gillison +17 more
TL;DR: In this article, the prevalence of human papillomavirus (HPV) infection in oropharyngeal cancer was determined for all 271 oropharygeal cancers (1984-2004) collected by the three population-based cancer registries in the Surveillance, Epidemiology, and End Results (SEER) Residual Tissue Repositories Program.
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
Maura L. Gillison,Wayne M. Koch,Randolph B. Capone,Michael Spafford,William H. Westra,Li Wu,Marianna Zahurak,Richard W. Daniel,Michael P. Viglione,David Eric Symer,Keerti V. Shah,David Sidransky +11 more
TL;DR: It is suggested that HPV-positive oropharyngeal cancers comprise a distinct molecular, clinical, and pathologic disease entity that is likely causally associated with HPV infection and that has a markedly improved prognosis.
3.2K
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
Jay S. Cooper,Thomas F. Pajak,Arlene A. Forastiere,John R. Jacobs,Bruce H. Campbell,Scott Saxman,Julie A. Kish,Harold Kim,Anthony J. Cmelak,Marvin Rotman,Mitchell Machtay,John F. Ensley,K.S.Clifford Chao,Christopher J. Schultz,Nancy M. Lee,Karen K. Fu +15 more
TL;DR: Among high-risk patients with resected head and neck cancer, concurrent postoperative chemotherapy and radiotherapy significantly improve the rates of local and regional control and disease-free survival, however, the combined treatment is associated with a substantial increase in adverse effects.
3.1K